Inequalities in non-small cell lung cancer treatment and mortality

Journal of Epidemiology and Community Health

Volumn 69, Issue 10, 2015, Pages 985-992

  Nur, Ula ^a   Quaresma, Manuela ^a   De Stavola, Bianca ^a   Peake, Michael ^b   Rachet, Bernard ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER; CELLS AND CELL COMPONENTS; DISEASE TREATMENT; EPIDEMIOLOGY; EQUITY; GEOGRAPHICAL VARIATION; HEALTH EDUCATION; HEALTH RISK; HEALTH SERVICES; MORTALITY;

ENGLAND; UNITED KINGDOM;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CARCINOMA, NON-SMALL-CELL LUNG; ECONOMICS; ENGLAND; EPIDEMIOLOGY; FEMALE; GEOGRAPHY; HEALTH CARE DISPARITY; HUMAN; INCIDENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MORTALITY; POVERTY; PRIMARY HEALTH CARE; PROCEDURES; REGISTER; SEX RATIO; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UTILIZATION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; ENGLAND; FEMALE; GEOGRAPHY; HEALTHCARE DISPARITIES; HUMANS; INCIDENCE; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POVERTY AREAS; PRIMARY HEALTH CARE; REGISTRIES; SEX DISTRIBUTION; SURGICAL PROCEDURES, OPERATIVE; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84945438249     PISSN: 0143005X     EISSN: 14702738     Source Type: Journal    
DOI: 10.1136/jech-2014-205309     Document Type: Article

References (45)

1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11. [Internet]. International Agency for Research on Cancer, 2014. http://globocan.iarc.fr (accessed 10 Jun 2014).
2. K CRU. UK cancer incidence statistics for common cancers. Secondary UK cancer incidence statistics for common cancers 2011/07/06/2011. http://info.cancerresearchuk.org/cancerstats/incidence/commoncancers/
3. Network NCI. Major surgical resections England, 2004-2006, 2011.
4. Riaz SP, Linklater KM, Page R, et al. Recent trends in resection rate among non-small cell lung cancer patients in England. Thorax 2012;67:811-14.
5. Devbhandari MP, Yang SS, Quennell P, et al. Lung cancer resection rate in south Manchester: is it comparable to international standards? Results of a prospective tracking study. Interact Cardiovasc Thorac Surg 2007;6:712-14.
6. Peake MD, Thompson S, Lowe D, et al. Ageism in the management of lung cancer. Age Ageing 2003;32:171-7.
7. Chambers A, Routledge T, Pilling J, et al. In elderly patients with lung cancer is resection justified in terms of morbidity, mortality and residual quality of life? Interact Cardiovasc Thorac Surg 2010;10:1015-21.
8. Network NCI. Cancer survival in England by stage 2012. 2014. https://www.gov.uk/government/publications/cancer-survival-in-england-by-stage (accessed 10 Jul 2014).
9. National Cancer Intelligence Network. Recent trends in lung cancer incidence, mortality and survival. 2013. http://www.ncin.org.uk/publications/data_briefings/recent_trends_in_lung_cancer_incidence:mortality_and_survival (accessed 6 November 2014).
10. Rachet B, Maringe C, Nur U, et al. Population-based cancer survival trends in England and Wales up to 2007: an assessment of the NHS cancer plan for England. Lancet Oncol 2009;10:351-69.
11. Coleman MP, Forman D, Bryant H, et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 2011;377:127-38.
12. Quaresma M, Whitehead S, Bannister N, et al. Index of cancer survival for Clinical Commissioning Groups in England; Patients diagnosed 1996-2011 and followed up to 2012. Office for National Statistics, 2013.
13. Riaz SP, Luchtenborg M, Jack RH, et al. Variation in surgical resection for lung cancer in relation to survival: population-based study in England 2004-2006. Eur J Cancer 2012;48:54-60.
14. Nur U, Coleman MP, Whitehead S, et al. Cancer Survival by Cancer Network in England- Patients diagnosed 1997-2010 and followed up to 2011. Office for National Statistics, 2012. 19 December 2012. http://www.ons.gov.uk/ons/rel/cancer-unit/cancer-survival-bycancer-network/patients-diagnosed-in-1997-2010-and-followed-up-to-2011/stb-cancersurvival-by-cancer-network--diagnosed-1997-2010-2011-follow-up.html
15. Rachet B, Falcaro M, Gordon E, et al. Geographic patterns of cancer survival in England-Patients diagnosed 2002-2004, followed up to 2009. Office for National Statistics, 2011. 26 May 2011. http://www.ons.gov.uk/ons/rel/cancer-unit/cancersurvival-by-gor--sha-and-cancer-network/geographic-patterns-of-cancer-survival-inengland/index.html
16. Department of Health. The NHS Cancer Plan: a plan for investment, a plan for reform. London, 2000.
17. Rosen R, Smith A, T H. Future Trends and Challenges for Cancer Services in England: A review of the literature and policy. 2006. http://www.kingsfund.org.uk/sites/files/kf/field/field_publication_file/future-trends-challenges-cancer-services-england-review-ofliterature-policy-rebecca-rosen-alex-smith-tony-harrison-kings-fund-24-august-2006.pdf (accessed 15/05/2014).
18. Rachet B, Quinn MJ, Cooper N, et al. Survival from cancer of the lung in England and Wales up to 2001. Br J Cancer 2008;99(Suppl 1):40-2.
19. Berglund A, Holmberg L, Tishelman C, et al. Social inequalities in non-small cell lung cancer management and survival: a population-based study in central Sweden. Thorax 2010;65:327-33.
20. Riaz SP, HortonM, Kang J, et al. Lung cancer incidence and survival in England: an analysis by socioeconomic deprivation and urbanization. J Thorac Oncol 2011;6: 2005-10.
21. Gregor A, Thomson CS, Brewster DH, et al. Management and survival of patients with lung cancer in Scotland diagnosed in 1995: results of a national population based study. Thorax 2001;56:212-17.
22. Jack RH, Gulliford MC, Ferguson J, et al. Geographical inequalities in lung cancer management and survival in South East England: evidence of variation in access to oncology services? Br J Cancer 2003;88:1025-31.
23. Cartman ML, Hatfield AC, Muers MF, et al. Lung cancer: district active treatment rates affect survival. J Epidemiol Community Health 2002;56:424-9.
24. Office of the Deputy Prime Minister. The English Indices of deprivation 2004-summary (revised). 2004. http://wwwcommunitiesgovuk/archived/publications/communities/indicesdeprivation (accessed 21 Sep 2010).
25. Health and Social Care Information Centre. HES online: Hospital Episode Statistics. 2008. http://wwwhesonlinenhsuk; http://www.hesonline.nhs.uk (accessed 2 May 2008).
26. Appleby J, Harrison T, Foot C, et al. Explaining variations in primary care trusts' spending on cancer services. 2011. 10 June 2011. http://www.kingsfund.org.uk/publications/articles/explaining-variations-primary-care-trusts-spending-cancer-services
27. Rabe-Hesketh S, Skrondal A. Multilevel and longitudinal modeling using Stata. 3rd edn. Stata Press, 2012.
28. Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med 1989;8:551-61.
29. Royston P, Parmar MKB. Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects. Stat Med 2002;21: 2175-97.
30. Spiegelhalter DJ. Funnel plots for comparing institutional performance. Stat Med 2005;24:1185-202.
31. Mayer EK, Bottle A, Rao C, et al. Funnel plots and their emerging application in surgery. Ann Surg 2009;249:376-83.
32. Quaresma M, Coleman MP, Rachet B. Funnel plots for population-based cancer survival: principles, methods and applications. Stat Med 2014;33: 1070-80.
33. Imperatori A, Harrison RN, Leitch DN, et al. Lung cancer in Teesside (UK) and Varese (Italy): a comparison of management and survival. Thorax 2006; 61:232-9.
34. Myrdal G, Lamberg K, Lambe M, et al. Regional differences in treatment and outcome in non-small cell lung cancer: a population-based study (Sweden). Lung Cancer 2009;63:16-22.
35. Peake MD, Black EA. Increasing the surgical resection rate for lung cancer in the UK: the debate. Lung Cancer Manag 2013;2:6.
36. Billing JS, Wells FC. Delays in the diagnosis and surgical treatment of lung cancer. Thorax 1996;51:903-6.
37. Crawford SM, Sauerzapf V, Haynes R, et al. Social and geographical factors affecting access to treatment of lung cancer. Br J Cancer 2009;101:897-901.
38. Raine R, Wong W, Scholes S, et al. Social variations in access to hospital care for patients with colorectal, breast, and lung cancer between 1999 and 2006: retrospective analysis of hospital episode statistics. BMJ 2010;340:b5479.
39. Pollock AM, Vickers N. Breast, lung and colorectal cancer incidence and survival in South Thames Region, 1987-1992: the effect of social deprivation. J Public Health Med 1997;19:288-94.
40. Ambrogi V, Pompeo E, Elia S, et al. The impact of cardiovascular comorbidity on the outcome of surgery for stage I and II non-small-cell lung cancer. Eur J Cardiothorac Surg 2003;23:811-17.
41. Martin-Ucar AE, Waller DA, Atkins JL, et al. The beneficial effects of specialist thoracic surgery on the resection rate for non-small-cell lung cancer. Lung Cancer 2004;46:227-32.
42. Silvestri GA, Handy J, Lackland D, et al. Specialists achieve better outcomes than generalists for lung cancer surgery. Chest 1998;114:675-80.
43. Wouters MW, Siesling S, Jansen-Landheer ML, et al. Variation in treatment and outcome in patients with non-small cell lung cancer by region, hospital type and volume in The Netherlands. Eur J Surg Oncol 2010;36(Suppl 1): S83-92.
44. Rich AL, Tata LJ, Free CM, et al. Inequalities in outcomes for non-small cell lung cancer: the influence of clinical characteristics and features of the local lung cancer service. Thorax 2011;66:1078-84.
45. Luchtenborg M, Riaz SP, Coupland VH, et al. High procedure volume is strongly associated with improved survival after lung cancer surgery. J Clin Oncol 2013;31:3141-6.